Iran vs Kyrgyzstan: Cause of death, by non-communicable diseases, ages 15-59, female
Iran
54.9%
in 2021
Kyrgyzstan
54.4%
in 2021
Iran rank
113th
Kyrgyzstan rank
116th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Iran
- Kyrgyzstan
How they compare
Iran currently reports 54.9% against 54.4% in Kyrgyzstan, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Kyrgyzstan ahead.
Iran ranks 113th and Kyrgyzstan ranks 116th of 185 countries.
Across the 3 decades both report, Iran averaged higher in 1 and Kyrgyzstan in 2.
Head to head by decade
| Decade | Iran | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.3% | 75.5% | 7.2% | Kyrgyzstan |
| 2010s | 74.0% | 78.9% | 4.8% | Kyrgyzstan |
| 2020s | 56.5% | 56.4% | 0.1% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Iran or Kyrgyzstan?
- Iran, at 54.9% against 54.4% in Kyrgyzstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Iran and Kyrgyzstan?
- 0.5%, with Iran ahead.
- How many years of comparable data are there for Iran and Kyrgyzstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Iran and Kyrgyzstan rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Iran ranks 113th and Kyrgyzstan ranks 116th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.